AFT Pharmaceuticals Limited (AFP.AX)
AUD 2.45
(7.93%)
AUD 2.45
(7.93%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 24.23 Million NZD | 23.21% |
| 2023 | 19.66 Million NZD | -3.53% |
| 2022 | 20.38 Million NZD | 90.41% |
| 2021 | 10.7 Million NZD | -6.9% |
| 2020 | 11.5 Million NZD | 73.3% |
| 2019 | 6.63 Million NZD | 176.77% |
| 2018 | -8.64 Million NZD | 42.12% |
| 2017 | -14.93 Million NZD | -72.54% |
| 2016 | -8.65 Million NZD | -45.11% |
| 2015 | -5.96 Million NZD | -285.83% |
| 2014 | 3.21 Million NZD | 14.07% |
| 2013 | 2.81 Million NZD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 3.25 Million NZD | -79.95% |
| 2024 Q4 | 20.98 Million NZD | 545.69% |
| 2024 FY | 24.23 Million NZD | 23.21% |
| 2023 Q2 | 3.45 Million NZD | -76.8% |
| 2023 FY | 19.66 Million NZD | -3.53% |
| 2023 Q4 | 16.21 Million NZD | 368.96% |
| 2022 Q4 | 14.89 Million NZD | 171.32% |
| 2022 FY | 20.38 Million NZD | 90.41% |
| 2022 Q2 | 5.49 Million NZD | -33.73% |
| 2021 Q2 | 2.42 Million NZD | -73.72% |
| 2021 FY | 10.7 Million NZD | -6.9% |
| 2021 Q4 | 8.28 Million NZD | 242.11% |
| 2020 Q4 | 9.21 Million NZD | 302.93% |
| 2020 FY | 11.5 Million NZD | 73.3% |
| 2020 Q2 | 2.28 Million NZD | -64.28% |
| 2019 Q2 | 235 Thousand NZD | 109.06% |
| 2019 FY | 6.63 Million NZD | 176.77% |
| 2019 Q4 | 6.4 Million NZD | 2624.26% |
| 2018 FY | -8.64 Million NZD | 42.12% |
| 2018 Q4 | -2.59 Million NZD | 57.15% |
| 2018 Q2 | -6.05 Million NZD | 10.01% |
| 2017 Q2 | -8.21 Million NZD | -59.95% |
| 2017 Q4 | -6.72 Million NZD | 18.09% |
| 2017 FY | -14.93 Million NZD | -72.54% |
| 2016 Q2 | -3.52 Million NZD | -123.12% |
| 2016 FY | -8.65 Million NZD | -45.11% |
| 2016 Q4 | -5.13 Million NZD | -45.7% |
| 2015 Q4 | -1.57 Million NZD | 64.0% |
| 2015 FY | -5.96 Million NZD | -285.83% |
| 2015 Q2 | -4.38 Million NZD | 0.0% |
| 2014 FY | 3.21 Million NZD | 14.07% |
| 2013 FY | 2.81 Million NZD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Althea Group Holdings Limited | -11.69 Million AUD | 307.172% |
| Cann Group Limited | -13.47 Million AUD | 279.798% |
| ECS Botanics Holdings Ltd | 1.43 Million AUD | -1584.565% |
| Ecofibre Limited | -15.02 Million AUD | 261.276% |
| Elixinol Wellness Limited | -5.99 Million AUD | 504.591% |
| Hygrovest Limited | -1.1 Million AUD | 2297.189% |
| IDT Australia Limited | -4.94 Million AUD | 589.695% |
| Invion Limited | -7.55 Million AUD | 420.9% |
| Little Green Pharma Ltd | -7.62 Million AUD | 417.719% |
| Live Verdure Ltd | -12.54 Million AUD | 293.259% |
| Medical Developments International Limited | -16.86 Million AUD | 243.683% |
| Vitura Health Limited | 4.86 Million AUD | -397.932% |
| Vita Life Sciences Limited | 12.21 Million AUD | -98.404% |